BlendCJC-1295 / Ipamorelin (No DAC)
CJC-1295 (without DAC) with Ipamorelin
A blended research vial combining modified GRF (1-29) with the selective growth hormone secretagogue ipamorelin.
Third-party tested · Purity 99% · For laboratory research use only.
- Purity
- 99%
- Form
- Powder (lyophilized blend)
- Available sizes
- 5/5mg
Mechanism of Action
CJC-1295 acts as a GHRH analogue on pituitary somatotrophs while ipamorelin acts on the ghrelin receptor, studied together for synergistic GH release in models.
Research Areas
- ●Growth hormone axis research
- ●Recovery and body composition models
- ●Sleep architecture studies